HUNTINGTON BEACH, Calif., Oct. 1 /PRNewswire-FirstCall/ -- iTech Medical, Inc. (OTC Bulletin Board: IMSU; FWB: 0IM), a medical information technology company, today provided an update on the Company's clinical and regulatory plans for its proprietary Muscle Pattern Recognition (MPR) System. MPR is a patented clinical tool that analyzes patterns of muscle recruitment. MPR provides detailed physiological information on muscle function that can assist in the diagnosis and treatment of back and neck injuries and illness.
iTech Medical is currently conducting a clinical trial of the MPR System at the Utah Spine and Joint Center in Salt Lake City, Utah. The trial began in February 2009 and to date, the Company has completed testing on more than 250 study subjects, many with chronic back pain. The Company stated that patient recruitment for the balance of the trial is being shifted to test subjects with recent, acute back injuries to allow for a more rigorous testing of the MPR data analysis system.
"The results of the clinical trial to date are very encouraging and we look forward to completing the study in the early part of 2010," stated Dr. Alan Goldman, Vice President, Clinical and Medical Affairs at iTech Medical. "Following the trial, we plan to submit our results to the FDA and to several peer-review journals for publication."
The Company also reported that it expects to begin a randomized, multi-centered clinical trial of the MPR System following the completion of the current trial. "The goal of this second clinical trial will be to independently demonstrate the capacity of MPR testing to objectively determine patient progress and outcomes," said Dr. Goldman. "We believe that the MPR evaluation modality will allow a physician, for the first time, to objectively identify and quantify the specific underlying physiological and biomechanical dysfunction that corresponds to an individual's subjective complaints. The ultimate goal of our clinical program is to demonstrate the effectiveness of using MPR in conjunction with AHCPR guidelines and physicians' clinical observations to help guide healthcare providers with the diagnosis, rehabilitation, and case management of sprain/strain back injuries."
Dr. Goldman discusses the technology behind Muscle Pattern Recognition (MPR) in this video which showcases the test procedure: http://www.itechmedical.com/itechtvAG.html
The Company also reported progress in its discussions with potential strategic partners regarding various joint ventures and partnerships for the commercialization of MPR. "We have been targeting specific regions in North America and the EU where we believe we will have the best opportunity at introducing MPR," said Wayne Cockburn, President and CEO at iTech Medical. "We are moving towards Heads of Agreements with several parties and hope to announce definitive agreements sometime following the successful completion of our financing."
About iTech Medical
iTech Medical, Inc. (OTCBB: IMSU, FWB: 0IM) is engaged in the research and commercial development of healthcare information systems and technologies. To date, the Company has focused on developing a proprietary platform called Muscle Pattern Recognition (MPR), a unique clinical tool for the analysis of muscle function. MPR is a patented clinical tool that analyzes patterns of muscle recruitment. It provides detailed physiological information on muscle function that can assist in the diagnosis and treatment of back and neck injuries and illness.
Forward-Looking and Cautionary Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that reflect management's current views and estimates regarding future market conditions, company performance and financial results, business prospects, new strategies, the competitive environment and other events. You can identify these statements by the fact that they use words such as "anticipate," "believe," "estimate," "expect," "intend," "project," "plan," "outlook," and other words and terms of similar meaning.
These statements involve a number of risks and uncertainties that could cause actual results to materially differ from the potential results discussed in the forward-looking statements. Among the factors that could cause actual results and outcomes to differ materially from those contained in such forward-looking statements are the following: general economic conditions, acquisitions and development of new businesses, divestitures, product availability, sales volumes, pricing actions and promotional activities of our competitors, profit margins, weather, changes in law or regulations, foreign currency fluctuation, availability of suitable real estate locations, our ability to react to a disaster recovery situation, and the impact of labor markets and new product introductions on our overall profitability.
A further list and description of these risks, uncertainties and other matters can be found in the company's annual report and other reports filed from time to time with the Securities and Exchange Commission, including, but not limited to, iTech Medical's Annual Report on Form 10-K filed with the SEC on April 15, 2009. iTech Medical cautions that the foregoing list of important factors is not complete and assumes no obligation to update any forward-looking statements that it may make.
SOURCE iTech Medical, Inc.
|SOURCE iTech Medical, Inc.|
Copyright©2009 PR Newswire.
All rights reserved